On December 20, 2018, it was learned that Zhizhi Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as the medical technology) officially announced the completion of several hundred million RMB B round of financing. This round of financing was led by Yuanyi Capital, and the preA round of investors invested in capital and investment, and the index capital exclusively served as financial advisor.
This round of financing will be used for the next phase of R&D investment and to expand the influence of China's most comprehensive cancer accurate medical data platform in the clinical field. Previously, at the beginning of the establishment of this medical technology, it was awarded the angel round investment led by IDG, and the investment institutions included volcanic stone capital and Songhe Capital.
The medical technology was established in May 2016. It focuses on high-tech research and development and clinical application transformation in the field of cancer. It conducts comprehensive detection of hundreds of cancer-related genes in pan-carcinogens, assists doctors in precise medicine, and promotes clinical treatment of cancer in China. Innovation.
Based on the world's advanced sequencing and biotechnology, rich clinical annotations and case experience, this medical technology has developed products that target all solid tumor types and can simultaneously guide targeted therapy and immunotherapy, and is the first to introduce precision treatment data sharing. APP Groundhog Dr.
Since the establishment of the medical technology, the strategic layout of Shanghai, Shenzhen, Shenyang, Taizhou and Jinan has been completed. At present, Zhizhi Medical Technology has more than 300 employees, covering hundreds of major hospitals nationwide and serving more than a thousand clinicians.
As an innovative company specializing in comprehensive tumor precision medical treatment, Zhiyuan Medical Technology is committed to becoming the leading enterprise in the accurate treatment of tumors in China with its unique biological information analysis algorithm and self-built tumor gene, clinical and drug database for the Chinese population.
In August 2017, Zhihua Medical Technology announced that Professor Matthew Meyerson, Professor of Global Cancer Genomics, Professor Gordon Freeman, the founder of immunotherapy, Professor Carlos Arteaga, a well-known clinical expert, and Professor Tony Mok, an international expert in lung cancer, officially decided to serve as the Medical Science and Technology Advisory Committee. .
In addition, Zhishi Medical Technology has established an international cooperation platform for international precision treatment of hepatobiliary and international pancreatic cancer with internationally renowned institutions such as the International Union of Cholangiocarcinoma Research (ICRN), MD Anderson, Mayo Clinic, and Massachusetts General Hospital (MGH). A number of international cooperation platforms such as the tumor board.
In August 2018, Zhihua Medical Technology successfully obtained the official certification of the American College of Pathologists (CAP), marking the quality management system, experimental technology level, information analysis and clinical interpretation of the medical technology in the laboratory. The normative and accurate aspects of all aspects have reached the world-class laboratory standards, and its inspection report has been approved by the American Association of Pathologists.
A series of bioinformatics analysis algorithms developed by the medical technology have obtained a number of patents to ensure that the sample analysis is more rigorous, precise and comprehensive.
In September 2018, at the China Cancer Congress CSCO, Zhiben Medical Technology announced that it will launch a big data platform for genetic informatics with Chinese characteristics in cancer with the CSCO Clinical Oncology Research Foundation and the Oriental Cancer Clinical Research Center. The Chinese gene sequencing industry has officially entered the era of big data integrating clinical data and genetic data.
Blackout greenhouse ,Light dep greenhouse ,Auto light deprivation greenhouse,Blackout green house,film greenhouse
JIANGSU SKYPLAN GREENHOUSE TECHNOLOGY CO.,LTD , https://www.thgreenhouse.com